Streptococcus pneumoniae antigens and vaccines
US6573082B1 · kind B1 · utility
84Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2000 |
| Grant date | Jun 3, 2003 |
| Priority date | — |
| Expiry date | Mar 28, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel vaccines for the prevention or attenuation of infection by Streptococcus pneumoniae. The invention further relates to isolated nucleic acid molecules encoding antigenic polypeptides of Streptococcus pneumoniae. Antigenic polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention additionally relates to diagnostic methods for detecting Streptococcus nucleic acids, polypeptides and antibodies in a biological sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.